GSK and Vir Biotechnology announce United States Government agreement to purchase additional supply of Sotrovimab
Synopsis : GlaxoSmithKline plc (LSE/NYSE: GSK) and Vir Biotechnology, Inc. (Nasdaq: VIR) announced that the US Government will purchase an additional 600,000…